Bokf, Na Royalty Pharma PLC Transaction History

Bokf, Na

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$26.26 - $29.9 $814 - $926	31 Added 0.17%	18,311 $482,000
Q1 2024 May 15, 2024	BUY	$27.46 - $31.33 $78,096 - $89,102	2,844 Added 18.42%	18,280 $555,000
Q4 2023 Feb 14, 2024	SELL	$26.21 - $29.22 $59,391 - $66,212	-2,266 Reduced 12.8%	15,436 $433,000
Q3 2023 Nov 14, 2023	BUY	$26.26 - $31.38 $333,502 - $398,526	12,700 Added 253.9%	17,702 $480,000
Q1 2023 May 11, 2023	BUY	$32.77 - $39.4 $163,915 - $197,078	5,002 New	5,002 $180,000
Q2 2022 Aug 11, 2022	BUY	$37.53 - $44.22 $187,725 - $221,188	5,002 New	5,002 $210,000
Q1 2022 May 13, 2022	SELL	$37.46 - $42.44 $288,816 - $327,212	-7,710 Closed	0 $0
Q4 2021 Mar 11, 2022	BUY	$35.17 - $42.48 $271,160 - $327,520	7,710 New	7,710 $307,000

483

283M

2.51M

941K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $14.3B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

Stay updated on Bokf, Na with notifications on news.